 | Joel A. Mintzer Robins, Kaplan, Miller & Ciresi L.L.P. 2800 LaSalle Plaza, 800 LaSalle Avenue Minneapolis, MN 55402 612-349-8500 (firm) 612-339-4181 (fax) Contact this attorney | |
Contact Lawdragon about the information in this review.
Practice Groups
Experience
- Focuses on complex litigation, often involving multijurisdictional, class action, and bankruptcy issues.
- Handles cases in employment, health care litigation, ERISA, and products liability litigation.
Outside Experience
- Law Clerk to the Honorable Harold D. Vietor, U.S. District Court, Southern District of Iowa
Selected Results*
- In re: Lorazepam and Clorazepate Antitrust Litigation: Representation of Blue Cross Blue Shield of
Massachusetts, Blue Cross Blue Shield of Minnesota, and Federated Mutual Insurance Company in litigation before the federal
District Court in the District of Columbia involving claims of state antitrust law violations regarding competitors' access
to raw materials for Lorazepam and Clorazepate. The jury's verdict found that Mylan Laboratories Inc./Mylan Pharmaceuticals
Inc., Cambrex Corporation, and Gyma Laboratories violated state antitrust laws and had restrained trade and acted willfully
in excluding generic competitors' access. In post-trial motions, the District Court awarded Plaintiffs treble damages, for
a total award to all plaintiffs of $76.8 million. The case has been remanded to the district court for further proceedings
following the D.C. Circuit opinion of January 18, 2011.
- Omnicare, Inc. v. UnitedHealth Group, Inc.: Represented defendants UnitedHealth Group, Inc. and PacifiCare, Inc. in an antitrust lawsuit involving alleged price-fixing and fraud related to prescription drug reimbursement under the federal Medicare Part D program. Plaintiff Omnicare sought damages exceeding $1 billion and permanent injunctive relief. After summary judgment motion was argued in August 2008, the U.S. District Court granted summary judgment to defendants on all claims in January 2009. Published decision: Omnicare, Inc. v. UnitedHealth Group, Inc., 594 F. Supp. 2d 945 (N.D. Ill. 2009). Summary judgment was subsequently affirmed. Omnicare, Inc. v. UnitedHealth Group, Inc., 629 F.3d 697 (7th Cir. 2011).
- In re Matter of Union Oil Company of Calif., FTC Docket No. 9305 (F.T.C.). Trial counsel for Unocal in action
brought by FTC alleging violations of Federal Trade Commission Act § 5 and monopolization under Sherman Act § 2, claiming
that Unocal monopolized the market for reformulated gasoline in California by failing to disclose its patents to the
California Air Resources Board and participants in the rule-making process. The case was tried to Administrative Law Judge
Michael Chappell, lasted four months, and involved the testimony of more than 40 witnesses. The case was settled shortly
after trial when Chevron acquired Unocal, while awaiting Administrative Law Judge's final decision.
- Representation of Blues plans and other health insurers in litigation against drug manufacturer for overpayments made
for the prescription drug Paxil and Paxil CR. After lengthy discovery and numerous pretrial motions on claims which included
allegations of antitrust violations arising from manufacturers' use of patents to keep generics out of the market, we
obtained settlement for our clients in the fall of 2008.
Blue Cross Blue Shield of Minnesota,
American Medical Security Life Insurance
Company, Blue Cross Blue Shield of
Massachusetts, Blue Cross Blue Shield of
Nebraska, Carefirst, Inc., Blue Cross Blue
Shield of Delaware, Inc., Excellus Health
Plan, Inc., Hawaii Medical Service
Association, Health Care Services
Corporation, Horizon Health Care Services,
Inc., Humana Inc., Louisiana Health Service
& Indemnity Company, Medical Mutual of
Ohio, Mutual of Omaha Insurance Company,
Oxford Health Plans, LLC, Wellmark, Inc.,
The Regence Group, Time Insurance
Company, Union Security Insurance
Company, John Alden Life Insurance
Company v. Glaxosmithkline plc, et al.
- Represented independent three-member Special Committee of the Fiesta Bowl Board of Directors that was headed by a former
Chief Justice of the Arizona Supreme Court. The Special Committee was formed to investigate allegations that the Fiesta Bowl
had reimbursed employees for campaign contributions, that a prior investigation had covered-up criminal conduct, and that
the Fiesta Bowl had made numerous other improper expenditures. Our five-month investigation included 87 interviews of 52
individuals and the review of 55 gigabytes of electronic data and more than 10,000 additional hard copy documents. Our
investigation culminated in a 276-page Final Report with 1,562 footnotes and thousands of additional pages of supporting
schedules and spreadsheets. The report is publicly available here. The Final Report
was covered by dozens of media outlets and has received widespread praise, including:
- The Arizona Republic's Editorial Board stated: "The Fiesta Bowl executive committee should never lose sight of what
appears to have saved their event's bacon, at least for now: the unflaggingly candid 276-page report released by the Fiesta
Bowl itself, which exposed all those ugly warts." Other reporting from The Arizona Republic referred to the report as
"comprehensive."
- A leading legal commentator stated: "Any lawyer or other person asked to lead a special investigation centered on
wrongdoing of the type that now surrounds the Fiesta Bowl should read RKMC's report first."
- Arizona Attorney General Tom Horne called the report "comprehensive."
- The Bowl Championship Series (BCS) Task Force -- a Task Force that was created to review the Fiesta Bowl's conduct and
our Report -- called our investigation "exceedingly thorough" and noted that had the Special Committee not produced such a
"thorough and open report" the Task Force "almost certainly would have recommended termination of the BCS Groups'
involvement with the Fiesta Bowl."
- NCAA President Mark Emmert stated that "The [Fiesta Bowl] special report was obviously extremely detailed and outlined
behaviors none of us would be supportive of and I think the board was forthright in putting all that information before the
various bodies."
- Sports Illustrated's Austin Murphy noted that the Special Committee's investigation (in contrast to an earlier
investigation) was "decidedly not a whitewash."
- DiMassa v. Medtronic AVE: Trade secret litigation concerning the Bonneau stent which was the platform for the
AVE business. The case was in jury selection when it settled, employing a creative settlement model. The case was then
arbitrated to a JAMS judge in San Francisco.
- Represented Unocal Corporation against ARCO, Chevron, Exxon, Mobil, Shell and Texaco in action for patent infringement
on reformulated gasoline technology.
* Past results are reported to provide the reader with an indication of the type of litigation in which we practice and
does not and should not be construed to create an expectation of result in any other case as all cases are dependent upon
their own unique fact situation and applicable law.
Bar Admissions
- Illinois
- Iowa
- Minnesota
- U.S. Court of Appeals, Seventh Circuit
- U.S. Court of Appeals, First Circuit
- U.S. Court of Appeals, Eighth Circuit
- U.S. Court of Appeals, Eleventh Circuit
- U.S. Court of Appeals, Fifth Circuit
- U.S. District Court, Minnesota
- U.S. District Court, Southern District of Iowa
Education
- Columbia University School of Law, J.D. (1989)
- University of Iowa, B.A. with highest distinction and with honors in Economics and Political Science
See Library Tab for articles, publications and presentations
by Joel Mintzer
| EVALUATION |
Fill in the requested information below, then submit your evaluation to have your scores calculated as part of
Joel A. Mintzer's
Lawdragon ranking.
By submitting this form, you agree to Lawdragon's TERM OF USE.
|
Q&A | Attorney Name: | | | | | | Law School Attended: | | | | | Favorite activities (besides the Law): | | | | | Favorite Sports Team (if you have one), or Favorite Theater or Museum, etc: | | | | | If you weren’t a lawyer, what would you be?: | | | | | What do you read most often: | | | | | Why are you proud to be a lawyer?: | | | | |
Joel Mintzer News
Articles
- Mass Actions: An Alternative for Mass Torts
Minnesota Trial Lawyer (Summer 1997) (co-authored)
Selected Speeches
- Where's the Action in 2011? Class Action Litigation in Review
Bureau of National Affairs, Webinar (November 18, 2011)
- New Law: Putting up with Dukes - Class Action Fights that Remain After Dukes v. Wal-Mart
Minnesota CLE, Webcast (September 27, 2011)
- Where's the Action?: The Interplay of Federal and State Class Litigation
Minnesota CLE, Webcast (August 10, 2011)
- Putting the Business Back in Business Litigation: Understanding the Intersection Between Business and Litigation
Minnesota CLE (June 7, 2011)
- Putting the Business Back in Business Litigation
Hennepin County Bar Association CLE (June 2011)
- Best Buy v. DDR - The Strategy, Outcome and Impact (Webinar)
NRTA (July 1, 2010)
- Purposeful Written Discovery: Taking the Offensive (Panel Discussion)
Minnesota CLE's First Litigation Advocacy Institute, Winning Before Trial, Minneapolis, Minnesota (June 4, 2009)
- Ethical Issues in Motion Practice Issues
Minnesota Association for Justice, Minneapolis, Minnesota (December 18, 2008)
- RICO and ERISA vs. HMOs: the Industry's Greatest Challenge?
Minnesota Institute of Legal Education (May 16, 2000)
|